跳到正文
原文
Medical Xpress·· 14 天前精选AI 评分70

AI驱动智能手表检测高血压的敏感度与诊室筛查相似

AI-powered smartwatch detects high blood pressure with sensitivity similar to office screening

AI 导读

研究利用AI算法分析智能手表数据,检测高血压的敏感度与传统诊室血压测量相当。该方法可作为识别高血压迹象的工具,有助于早期诊断和干预。

推荐理由

AI算法在智能手表上检测高血压的准确度与传统诊室血压测量相当,有助于早期诊断。

正文 · 原文
Smartwatch
Credit: Unsplash/CC0 Public Domain

Smartwatches may be able to detect hypertension (high blood pressure) with the help of an artificial intelligence (AI) system that interprets sensor readings, a paper in Nature reports. Tests of the system, trialed using a consumer smartwatch, show that it can detect hypertension at similar sensitivities to traditional office-based blood pressure screening methods.

Hypertension is a major risk factor for cardiovascular disease, but over half of affected adults are unaware of their condition. Wearable technology has the potential to detect signals of hypertension, although the sensors are typically not good enough for the direct measurement of blood pressure and readings need to be calibrated against traditional cuff blood pressure measurements.

Recent research has suggested that deep learning could help, but previous assessments have not used gold-standard blood pressure monitoring methods as reference points and have not compared measurements with established hypertension screening methods.

Estimating hypertension risk without cuff calibration

Ming-Zher Poh and colleagues show that applying an AI algorithm to signals recorded using a Google smartwatch can detect hypertension with accuracy levels comparable to traditional office-based cuffed blood pressure devices.

The smartwatch performs photoplethysmography (an optical technique that measures changes in blood volume in microvascular tissue beneath the skin) and uses an accelerometer to measure wrist motion. Combining these measurements with participant height and running them through an algorithm produces an estimated probability of hypertension without cuff calibration. This estimate requires multiple readings.

Detection comparable to office screening

The system was trained using nearly 500,000 hours of smartwatch data collected from 2,109 people, with additional testing and training in several cohorts. The approach was then validated in 196 participants by comparing the smartwatch-estimated presence of hypertension and standard office blood pressure measurements, evaluated against reference 24-hour ambulatory blood pressure monitoring, the gold-standard clinical monitoring method.

Detection of hypertension was comparable between the smartwatch system and standard office measurements. The smartwatch correctly identified slightly more cases of hypertension than office-based cuffed monitoring, with sensitivities of 65.8% and 55.3%, respectively, but the differences were not statistically significant. Both methods had equal specificities (successfully avoiding false positives 90% of the time).

The authors note that their system would not replace traditional cuff-based blood pressure monitoring but could act as a tool to identify individuals with signs of hypertension, which could facilitate earlier diagnosis and intervention and may reduce the occurrence of cardiovascular events.

Publication details

Paolo Di Achille et al., Opportunistically Detecting Signs of Hypertension on a Consumer Smartwatch, Nature (2026). DOI: 10.1038/s41586-026-11336-3

Journal information: Nature

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: AI-powered smartwatch detects high blood pressure with sensitivity similar to office screening (2026, November 6) retrieved 6 November 2026 from https://medicalxpress.com/news/2026-11-ai-powered-smartwatch-high-blood.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com